Clinical Trial Update: Effects of a Widely Used Vaccine Adjuvant in Subjects With Early Alzheimer's Disease Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients With Early Alzheimer's Disease - ADVANCE [Phase 2]

View source ↗

Summary

A Phase 2 double-blind trial (ADVANCE) is evaluating the safety and efficacy of the AD04 vaccine adjuvant in patients with early Alzheimer disease; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Early Onset

Drugs mentioned

• AD04

Snippet

Sponsor: ADvantage Therapeutics | Conditions: Alzheimer Disease, Early Onset | Phase 2 | Status: ACTIVE_NOT_RECRUITING